Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO). [Phase 3]

View source ↗

Summary

APOLLO is a Phase 3 trial evaluating fondaparinux sodium with intermittent pneumatic compression versus IPC alone to prevent venous thromboembolism in high-risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED